Trabedersen (AP12009), specific for TGFB2 mRNA, reduced TGFB2 expression in human pancreatic cancer cell lines, resulted in decreased proliferation and migration, and reversed immunosuppressive effects (Figure 1A) (85). This evidence concerns the gene TGFB2 and familial pancreatic carcinoma.